Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
LDL Management – Why it is Important
Navigating Expanded PBS Access to SGLT2i in General Practice
Cervical Cancer Prevention – Common Questions
Asthma Cases – When to Use Dual vs Triple Therapy
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis